GDHN webinar: What Does It Really Cost to Develop Global Digital Health Goods? - Shared screen with speaker view - Recording 2/2
Hi, I’m Dave Potenziani at IntraHealth. I’ll be wrangling the questions submitted through chat. Please include who you are and your affiliation with your question.
Also, please introduce yourselves generally in the chat so we know who is on the call. - thanks to Guiliana for starting us off.
Hi everyone, I'm Paula Quigley from DAI Global Health. Pleasure to join this meeting.
Andrea King - Dimagi
Hello - this is Andrea King joining from Dimagi out of the US
Hi, I am Waldo Delport, from Qode Health Solutions, South Africa
Hello - this is Cassie Morgan with Cooper/Smith, joining you from Malawi
Hello! This is Gina Kuypers from PATH joining from Seattle.
Good morning - I’m Drew Arenth from macro-eyes, we are a machine learning/AI company building proactive supply chain technology. Partner of Gates Foundation, USAID, and many of the development organizations on this call!
Hi- This is Winnie Mwebesa from Save the Children, based in DC
Hi - this is Danielle Dhillon from DIAL (UN Foundation) from DC
Hi, Sarah Iribarren from the University of Washington, Seattle
Hi, Jane Passmore here from Praekelt.org in South Africa
hi this is sharif from uganda , nice to be here due to openmrs open source cause
Hi Fernanda Matsinhe , from Mozambique
Hi, I'm Chiara Kunnie from Praekelt.org, based in UK
Hello, Claire Cravero from Zenysis, calling in from Nairobi
Hi, Valeriya Biryukova, Arlington-based Cardno Emerging Markets
Hi! Chiara and everyone! Tara from Praekelt.org based in NYC.
Marissa Gilman - Resonance
Hi all, this is Marissa Gilman from Resonance Global calling from San Francisco
Hi, this is Sultana from Tanzania
HI--This is Trinity, the other Co-Chair of the GDHN and Associate Director, Research Utilization at FHI 360.
Hi everyone, I am Nancy Brown from SystemOne based in Massachusetts
Hi, this is Craig Arnold from World Food Programme
From here in NC, its Wayan Vota, Dave Potenziani, Allison Connolly, Jenny Mwanza, Venera Urbaeva, Christina Villella.
Fun Fact - we recently found this article which listed CommCare as the 54th most valuable repository out of 96 million repositories on GitHub according to their methodology: https://hackernoon.com/githubs-top-100-most-valuable-repositories-out-of-96-million-bb48caa9eb0b
Hi everyone, my name is Gibril Gomez - representative of OpenMRS Inc.
Hi everyone- Caitlin Madevu-Matson with JSI calling in from Boston
Neha Verma, Intelehealth
Hi this is Neha from Intelehealth, we’re a telemedicine solution built on top of OpenMRS.
Questions are now open. Please send yours in.
hi everyone, I’m Jean Pierre from Jembi Cameroon
Question: value creation and value capture are different. the "valuation" of the codebases (e.g. $76M for OpenMRS) represents an asset value. the USERS of this EMR capture this value... as Terry said... this asset impacts ~8M lives. can we not look for a way to connect the sustaining of the valuable asset to those that are CAPTURING value from it? can we not look for an annual maintenance & enhancements fee to be paid by our MOH partners who are capturing value from our global public goods?
(I'll address on my response)
The initial investments are substantial in retrospect. For those who were present before the creation of these platforms, if you had understood the development and initial implementation costs, would you have plunged into the venture?
We seem to have reached a maturity plateau with many of these applications. If the entry costs for a new player are in the realm of millions, where will the breakthrough innovations come from.
I am very interested to know the panelists opinions about why or how the OpenLMIS business model was unsustainable and the future for that product
Scott: great Q! here is a background post too https://www.ictworks.org/openlmis-open-source-software/
Certain products such as OpenMRS could potentially find a large market in developed countries - that could support more substantial user fees - helping to subsidize software support and development efforts across the developing countries. Has it been an intentional strategy to focus on developing country use cases only?
That was my question as well, thanks Randy!
I feel very awkward about raising this... but why does there seem to be a built-in assumption that the DONORS need to sustain the global goods? Our MOH partners do not have large health budgets... but should they not be devoting a proportion (2%?) of those not-large budgets to sustaining their domestic digital health projects? And if they did... would it provide enough of a recurring revenue stream to sustain the global goods that are supporting their health systems? Has anyone done this math??
What are the market failures in this sector that result in the type of outcome of a mature, large scale product like OpenLMIS
If you want to continue the discussion on market failures, I have thoughts! firstname.lastname@example.org
thanks all... this was a really insightful panel discussion! much appreciated!
Where can we get the presentation?
Please feel free to reach out Terry@openmrs.org
Great discussion, thank you!
yes, DHIS2/UiO would love to talk about that Jonathan. I'll reach out
MOH in those countries are developing their own systems through donors support as well, just close the loop of self-reliance and sustainability of gg.